A 14-year-old male neutered domestic shorthair cat presented for a recurrent angiosarcoma. Previously, the mass was incompletely resected twice at the referring practice with subsequent dehiscence and recurrence. The lesion was re-excised with dirty margins and the cat was treated with courses of adjunct chemotherapy (doxorubicin and toceranib) until progression of the angiosarcoma was noted four months after surgery. A fourth surgery was performed, resecting the mass en bloc with 2 cm margins and one fascial plane, achieving clean margins. Doxorubicin was resumed postoperatively, but nine weeks later another inguinal mass developed. Electrochemotherapy with intravenous bleomycin was elected as a rescue treatment, which resulted in complete response for three months. One month later, the patient presented with anaemia, tachycardia, tachypnoea and hypothermia. Staging revealed renal and pulmonary nodules. Due to declining quality of life and progressive disease, the owners elected euthanasia, at which time the cat had survived 13 months following initial diagnosis.
- feline angiosarcoma
- multimodal chemotherapy
Statistics from Altmetric.com
Contributors All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the concept, writing, or revision of the manuscript. Furthermore, each author certifies that this material or similar material has not been and will not be submitted to or published in any other publication before its appearance in VetRecords Case Reports.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.